Answers are grounded in this paper and cite their sources.
Oral cancer, strongly linked to modifiable risk factors, remains a significant public health challenge. Emerging evidence suggests that phytochemicals, which are naturally occurring bioactive compounds in plants, may play a potential role in oral cancer therapy. In the present review, a narrative synthesis of the literature was conducted to examine the role of phytochemicals in oral cancer prevention and adjunctive therapy. Phytochemicals demonstrate antioxidant, anti‑inflammatory and anti‑proliferative properties that contribute to their anticancer potential. Current evidence indicates that phytochemicals, such as curcumin, anthocyanins, epigallocatechin‑3‑gallate, S‑allylcysteine, quercetin, lycopene and resveratrol exert antitumor effects. However, suboptimal aqueous solubility, limited systemic bioavailability and insufficient molecular targeting frequently constrain phytochemical‑based interventions. On the whole, phytochemicals exhibit promising anticancer activity in preclinical models of oral squamous cell carcinoma. Clinical validation is required to address limitations in bioavailability, rapid metabolism and heterogeneous pharmacological properties.
No takes yet. Share an insight, caveat, or question.
Sathiyamoorthy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: